547 TumorNLRP3amplification suppresses NLRC5 expression and MHC class I antigen processing and presentation while driving anti-PD-1 immunotherapy resistance

DOI: 10.1136/jitc-2024-sitc2024.0547 Publication Date: 2024-11-05T14:58:58Z